Elanco Animal Health's EBIT rose 14925.37% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 10529.27%. This contributed to the annual value of -$1.5 billion for FY2024, which is 5153.55% up from last year.
Elanco Animal Health's EBIT amounted to $167.0 million in Q3 2025, which was up 14925.37% from $221.0 million recorded in Q2 2025.
In the past 5 years, Elanco Animal Health's EBIT registered a high of $249.0 million during Q1 2025, and its lowest value of -$1.6 billion during Q3 2023.
Moreover, its 5-year median value for EBIT was -$516.0 million (2022), whereas its average is -$457.3 million.
Per our database at Business Quant, Elanco Animal Health's EBIT tumbled by 20697.67% in 2023 and then surged by 14950.3% in 2025.
Over the past 5 years, Elanco Animal Health's EBIT (Quarter) stood at -$635.0 million in 2021, then rose by 15.43% to -$537.0 million in 2022, then dropped by 19.74% to -$643.0 million in 2023, then increased by 14.15% to -$552.0 million in 2024, then skyrocketed by 130.25% to $167.0 million in 2025.
Its EBIT was $167.0 million in Q3 2025, compared to $221.0 million in Q2 2025 and $249.0 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value